<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-14T18:55:54Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.08578" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.08578</identifier>
    <datestamp>2023-06-01T08:42:34Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2023-06-01</dc:date>
  <dc:title>A Randomized, Double-Blind Controlled Trial of Retrograde Colonic Enema Based Fecal Microbiota Transplantation in the Treatment of Childhood Constipation</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.08578</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>Datas are from a randomized, double-blind, controlled trial of 110 children (NCT 05035784).All participants received a daily RCE followed by a 4-week FMT treatment (twice a week) and a 12-week follow-up period. Before treatment, during 4 weeks of treatment, and 12 weeks of follow-up, the spontaneous bowel movements (SBMs) &amp;ge; 3 per week, and the RR with 95% CI were calculated as the main outcomes. Changes in the intestinal bacterial profile were analyzed by BOX-PCR-based DNA fingerprinting and sequencing at baseline and the end of the follow-up. The adverse effects were assessed based on symptoms. At the end of the follow-up period, 22 patients (40.0%) in the FMT with RCE group and 10 patients (18.2%) in the placebo with RCE group had &amp;ge; 3 SBMs per week (Net difference 21.8%, 95%CI 13.2% to 30.4%; RR1.364, 95%CI 1.063 to 1.749; P&amp;lt;0.05).&amp;nbsp;</dc:description>
  <dc:subject>children; constipation; fecal microbiota transplantation; gastroenterology; colonic enema; microorganism</dc:subject>
  <dc:creator>Xu GU</dc:creator>
  <dc:creator>Fan YANG</dc:creator>
  <dc:creator>Xuzheng JIANG</dc:creator>
  <dc:creator>Zheying SHEN</dc:creator>
  <dc:creator>Yao ZHANG</dc:creator>
  <dc:creator>Yang WANG</dc:creator>
  <dc:creator>YING chen</dc:creator>
  <dc:creator>Enhui WANG</dc:creator>
  <dc:creator>Shucheng ZHANG</dc:creator>
  <dc:rights>PUBLIC</dc:rights>
  <dc:rights>https://creativecommons.org/publicdomain/zero/1.0/</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>